Pain Management

Precedence Research announces a report regarding growth in the market size and trends of controlled substances in the US.

Nonopioid pain relief medications include acetaminophen, nonsteroidal anti-inflammatory drugs, suzetrigine, and adjuvant pain management drugs.

Opioid pain care shifts fast, and pharmacists and pharmacies lead safer prescribing, naloxone education, and monitoring to curb overdose deaths.

Pharmacists have the expertise to address acute and chronic pain distinctions, missed-dose protocols, tolerance and safety insights, and multimodal, non-pharmacological strategies for pain.

The drug could be an effective analgesia with a safety profile that could fundamentally alter the landscape of pain management and addiction treatment.

Combining medical, rehab, psychological, and complementary therapies offers more person-centered relief for chronic pain.

Pharmacists play an important role in guiding safe and effective OTC pain management, ensuring optimal patient care and minimizing risks.

This December 2025 order is an extension of HHS’ recommendation to reconsider marijuana as a Schedule III medication in 2023.

Pharmacists play a crucial role in pain management, offering personalized advice about medications and nonpharmacologic options to enhance patient care.

Progress against the opioid crisis shows promise, with overdose deaths declining, and pharmacists play a crucial role in life-saving medication strategies.

Living in West Virginia for over a decade, Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his experience as a practicing pharmacist amid the US opioid crisis.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his pain management expertise and discusses current developments in the US opioid epidemic.

Pharmacists can help patients navigate the vast array of OTC options for effective pain relief, fever reduction, and targeted symptom management.

Pennsylvania’s departments of health and human services provided written guidelines to support community pharmacists in delivering care for patients with opioid use disorder.

Balancing opioid use with compassion and clinical best practices ensures safe and patient-centered care, supporting pain management and addiction.

Since 2016, the rate of gabapentin prescribing slowed but is still increasing, especially for women and older adults.

Detailing the public health impact of an Rx-to-OTC switch, researchers explored the reclassification of triptan medications in Germany.

Chronic pain affects many older adults, highlighting the need for safe acetaminophen use and effective pain management strategies.

Rescheduling cannabis empowers pharmacists to lead in patient care by evaluating safety, interactions, and formulations while providing education.

Researchers presented findings from a pharmacist-led pilot program for opioid deprescribing among patients in a palliative care clinic.

The FDA also recommended a scheduling action for 7-hydroxymitragynine (7-OH), with data showing the drug binds to opioid receptors.

Pharmacists play a role in educating patients as well as making them feel more comfortable when utilizing opioid use treatment.

In 2023, drug overdose deaths sustained declines, but there are still disparities that need to be addressed to continue to decrease these numbers.

Chronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.

Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.